SLC22A3 and neoplasm: Slc22A1 mRNA was 1.8-fold (+/− 0.2-fold) lower in tumor tissue of Oct3−/− mice, and 0.3-fold (+/− 0.09-fold) lower in tumors of WT mice, compared to TST.